Home Blog Page 1076

IIT Madras strengthens Southeast Asia presence through strategic partnership in Singapore

CHENNAI, India, Feb. 6, 2026 /PRNewswire/ — India’s leading institution for higher education, the Indian Institute of Technology Madras (IIT Madras), is expanding its global footprint through a new established entity IIT Madras Global Research Foundation (IITM Global).

Indian External Affairs Minister Dr S Jaishankar (3rd L) releases a book on ‘India’s Innovation Ecosystem Going Global’ on 2 Jan at IITM, India
Indian External Affairs Minister Dr S Jaishankar (3rd L) releases a book on ‘India’s Innovation Ecosystem Going Global’ on 2 Jan at IITM, India

ITM Global’s charter pivots on four key pillars of Growth stage deep-tech startups, Research & Consultancy, IPs & Transfer of Technology and High Academic & Skilling programs.

IITM Global is a plug-and-play platform that has been newly launched by Dr. S. Jaishankar, Hon’ble Minister of External Affairs, Government of India. The initiative supports IIT Madras’s vision to become the world’s first multinational university by positioning it as a globally networked hub for education, research, innovation and entrepreneurship.

Addressing the IITM Global launch event at IIT Madras Campus on 2nd Jan 2026 Dr. S. Jaishankar said,An IIT Madras Campus in Tanzania is a way by which Indian Foreign Policy has leveraged the capabilities of an Institution here to make a huge impact. In ten years from now, think how many Students of Africa would have passed through its portals. Look at the impact that we would have on the minds of people who, in their own countries, would be economic and technology leaders. We are a human resource power and we should play to our strengths. We now have the capability to start doing so. When institutions of excellence in the country start going abroad, the business of foreign policy gains a huge addition to our arsenal. This is something very transformational.

As part of its South Asia expansion, IITM Global has partnered with GATES to build a long-term, market / customer connected innovation ecosystem focused on growth stage startups (Scaleups). The collaboration will serve as a strategic gateway for IITM Global deepen engagement with the tech ecosystem that serves ASEAN countries hence enabling startups to gain access to the growth markets of the region.

This strategic partnership will support scaling of startups incubated by IIT Madras into ASEAN. An additional focus of the collaboration will be the commercialisation of intellectual property developed at IIT Madras.

The partnership will facilitate structured licensing frameworks and industry engagement to translate cutting-edge research into deployable technologies with global relevance. By connecting academic research, startups and industry partners, IITM Global and GATES aim to create clear pathways from laboratory innovation to market impact.

Through its partnership with GATES IITM Global, aims to strengthen cross-border collaboration, enable startup internationalisation and create new avenues for globally impactful research, technology commercialisation across Southeast Asia and beyond.

Widely recognised as India’s top-ranked institution for higher education, IIT Madras is ranked #1 Overall and #1 Engineering Institute in India’s National Institutional Ranking Framework (NIRF), #180 in the QS World University Rankings and #56 in the QS Asian University Rankings. The institute hosts a comprehensive research ecosystem.

 

Phemex Introduces 24/7 TradFi Futures Trading with 0-Fee Carnival, Creating an All-in-One Trading Hub

APIA, Samoa, Feb. 6, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, announced the launch of Phemex TradFi, a new futures trading offering that allows users to access traditional financial assets, including stocks and precious metals, on a 24/7 basis. Futures linked to commodities, foreign exchange, and global indices will be introduced in subsequent phases.

Phemex Introduces 24/7 TradFi Futures Trading with 0-Fee Carnival, Creating an All-in-One Trading Hub
Phemex Introduces 24/7 TradFi Futures Trading with 0-Fee Carnival, Creating an All-in-One Trading Hub

The launch marks Phemex’s entry into multi-market derivatives, enabling traders to manage exposure to both crypto and traditional assets within a single, USDT-settled futures framework. To support early adoption, Phemex is introducing a 0-Fee TradFi Futures Carnival, offering three months of zero trading fees, starting from February 6, on stock futures alongside a $100,000 incentive pool aimed at structured and risk-aware participation, and a first-trade protection mechanism that reimburses eligible users with trading bonus if their initial TradFi futures trade results in a loss.

Unlike spot markets that are constrained by exchange hours, TradFi futures continue price discovery outside standard trading sessions. By bringing this derivative structure into a crypto-native environment, Phemex allows users to respond to global macro events as they unfold, whether during nights, weekends, or market closures—without switching platforms or settlement systems.

Phemex TradFi is designed for traders seeking simplicity and continuity across markets. Users can trade crypto and traditional futures side by side, benefit from transparent maker-taker pricing rather than spread-based execution, and apply strategy-driven tools to manage risk more systematically. Copy trading support for TradFi futures is also planned, extending Phemex’s strategy trading ecosystem into traditional markets.

“As markets become more connected and operate beyond fixed sessions, platforms need to evolve with them” commented Federico Variola, CEO of Phemex. “Our goal with Phemex TradFi is not to replicate traditional markets, but to rethink how they are accessed — bringing continuous availability, unified settlement, and risk-aware tools into a single trading environment that reflects how traders actually operate today.”

The introduction of TradFi futures signals Phemex’s evolution from a crypto-native exchange into a broader derivatives platform built for always-on global markets. As additional asset classes roll out, Phemex aims to offer traders a more integrated, resilient, and forward-looking way to navigate both digital and traditional finance.

About Phemex
Founded in 2019, Phemex is a user-first crypto exchange trusted by over 10 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products designed to prioritize user experience, transparency, and innovation. With a forward-thinking approach and a commitment to user empowerment, Phemex delivers reliable tools, inclusive access, and evolving opportunities for traders at every level to grow and succeed.

For more information, please visit: https://phemex.com/ 

AITO and ADM Enter into Strategic Partnership, Marking a New Chapter in the Global Expansion of Intelligent Luxury

CHONGQING, China, Feb. 6, 2026 /PRNewswire/ — AITO, China’s luxury intelligent vehicle brand, has officially signed a strategic cooperation agreement with Performance Plus Motors (subsidiary of Abu Dhabi Motors), a leading luxury automotive dealer group in the United Arab Emirates. The agreement was signed in Chongqing, China by Jason Wang, President of SERES AUTO Overseas BU, and Syed Faiz Karim, CEO of Abu Dhabi Motors. Leon He, President of SERES AUTO, and Kelvin Zhao, Chief Representative of ADM China, attended the signing ceremony as witnesses. This partnership marks a major milestone in AITO’s expansion into overseas luxury new energy vehicle markets and signals the official launch of the brand’s next phase of global growth.

Signing Ceremony
Signing Ceremony

With 40 years of industry experience, ADM has become one of the Middle East’s most influential luxury automotive dealer groups, supported by an extensive sales network, strong high-net-worth customer base, and professional operations and services. Its customer-centric philosophy and business innovations have set benchmarks for the industry. AITO has become the fastest emerging NEV brand to surpass one million units in production, achieved in just 46 months. The flagship AITO 9 has led China’s RMB 500,000+ segment for 21 consecutive months, reinforcing AITO’s leadership in luxury intelligent mobility with its strong product strength.

This strategic partnership will create a strong mutual empowerment, continuously strengthening core competitiveness across the luxury automotive space. Through deep collaboration, the two parties will embark on a new chapter in the Middle East’s intelligent luxury vehicle market, achieving shared value growth for both the brand and the market.

Performance Plus Motors, subsidiary of ADM, will be responsible for the sales, delivery, and after-sales service of AITO’s luxury intelligent models in the UAE, with plans to establish brand experience and service centers that deliver in-depth user experiences aligned with AITO’s positioning. At the same time, ADM will leverage market insights to drive localized marketing and brand communications, supporting AITO’s accelerated entry into the region’s high-end consumer segments. The two parties will also collaborate across customer service, market intelligence and resource sharing, aiming to build a long-term, win-win partnership.

Jason Wang, President of SERES AUTO Overseas BU and Syed Faiz Karim, CEO of ADM
Jason Wang, President of SERES AUTO Overseas BU and Syed Faiz Karim, CEO of ADM

Jason Wang, President of SERES AUTO Overseas BU, stated: “Our collaboration with ADM is an important milestone in AITO’s globalization strategy and marks a new starting point for joint exploration of the luxury NEV market in the Middle East. ADM’s extensive experience and resources in the local luxury automotive market will provide strong support for AITO’s local operations. This mutual effort will not only bring intelligent innovation to the Middle Eastern luxury car market but also drive AITO’s technological capabilities to achieve greater breakthroughs in the global market.”

Syed Faiz Karim, CEO of ADM, said: “AITO’s technological capabilities, product quality, and luxury brand positioning align closely with the demands of the Middle East’s high-end market and match our philosophy of cultivating the luxury segment and pursuing exceptional experiences. We will leverage our channels, resources, and operational advantages to fully support AITO’s long-term development in the UAE market, explore new opportunities in the luxury NEV segment, and continuously deliver more innovative and luxurious mobility experiences.”

Middle East  AITO Models Road Test
Middle East AITO Models Road Test

AITO models have completed localized hardware and software adaptation and required certifications. The flagship AITO 9 has begun local user test drives in the UAE, marking a pioneering move by a Chinese brand to engage overseas users. At the same time, AITO vehicles have arrived at Dubai port, ready for immediate delivery upon official launch. ADM’s well-established local infrastructure will also provide a solid foundation for AITO’s product launch, delivery, and long-term operations in the UAE. AITO will continue to develop its presence in the Middle East, laying the foundations for expansion into surrounding regions, while steadily enhancing the brand’s international presence and advancement in the global luxury intelligent NEV market.

  

Abu Dhabi Launches Art Customs Duty Waiver Programme to Attract and Support Global Collectors

The programme ensures due diligence, documented provenance, ownership transparency, and alignment with legal and compliance standards.

ABU DHABI, UAE, Feb. 6, 2026 /PRNewswire/ — The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) has announced the launch of a pioneering art customs duty waiver programme that will position the emirate as one of the world’s most trusted and forward-looking destinations for the long-term placement, conservation, and exhibition of high-value artworks. The initiative is established as a framework that prioritises governance, legal clarity, and institutional oversight as the foundation for participation.

© Department of Culture and Tourism – Abu Dhabi
© Department of Culture and Tourism – Abu Dhabi

Developed as part of Abu Dhabi’s broader cultural strategy, the programme offers a unique framework for high-net-worth collectors, family offices seeking a secure and expertly governed environment for the preservation of significant artworks valued from AED 10 million (US$2.72 million). It also ensures due diligence, documented provenance, ownership transparency, and alignment with applicable legal and compliance standards.

The art customs duty waiver programme is eligible for art brought into Abu Dhabi for a minimum term of three years, providing collectors with enhanced flexibility through a six-month export window. At launch, the programme focuses on regulatory certainty and structured oversight, with additional operational services evolving in a phased manner in the coming few months. Participants will also benefit from opportunities for art to be considered for scholarly study, research, and curated public engagement.

A specialised committee, comprising global experts will evaluate incoming submissions to ensure alignment with the programme’s standards and DCT Abu Dhabi’s commitment to safeguarding cultural assets of exceptional significance. This review process forms part of a broader governance approach designed to reinforce transparency, traceability, and responsible participation. A dedicated digital portal will allow collectors and family offices to submit expressions of interest, access programme details, and engage directly with advisory experts.

Through the programme, DCT Abu Dhabi reinforces the emirate’s position as a global cultural capital that provides not only world-class museums and institutions, but also the governance frameworks required to protect and elevate significant private collections. The Department’s approach differentiates itself by leading with regulation ensuring that long-term cultural development is supported by robust policy foundations.

The initiative is aligned with a long-term strategy to grow its cultural and creative industries, deepen international partnerships, and promote responsible, future-oriented cultural investment. Success will be measured by regulatory integrity, effective oversight, and adherence to international best practice. By offering a stable and transparent regulatory environment, Abu Dhabi aims to support collectors in preserving their legacies while contributing to global cultural understanding.

Applications for the programme will open through the official digital portal, enabling collectors and family offices worldwide to connect with the programme team and begin the eligibility assessment process. Further details will be made available to interested parties upon request.

Bybit Partners with Mercuryo to Offer Zero Transaction Fee for Crypto Purchases in Selected Markets

DUBAI, UAE, Feb. 6, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announced an exclusive partnership with Mercuryo, a global payments infrastructure platform, eliminating transaction fees on qualifying crypto purchases. From February 4, 2026 until February 18, 2026, eligible users can enjoy zero fees on transactions valued between 100 EUR and 500 EUR (or equivalent) through Bybit One-Click Buy.

During the promotional period, eligible Bybit customers in in-scope countries can take advantage of the zero-fee offer for a limited time when purchasing USDC or USDT using any of seven supported fiat currencies.

To enjoy the exclusive zero-fee offer, eligible users may log into their Bybit Account, navigate to Bybit One-Click Buy, and select Mercuryo as their payment method and select USDT or USDC as the payment currency. The limited-time offer eliminates standard transaction costs, allowing customers to convert their full payment amount into cryptocurrencies.

Bybit One-Click Buy is a streamlined feature that simplifies the crypto acquisition process, allowing users to convert supported fiat currency directly into digital assets within seconds. With multiple payment providers integrated, Bybit One-Click Buy offers competitive rates and fast processing for transactions.

Mercuryo is a global payments infrastructure platform in the digital token space. Standing out in the decentralized ecosystem by enhancing payment use case growth and on-chain integration, Mercuryo’s intuitive and robust solutions are powering the next generation of Web3 payment services. Mercuryo’s innovative payment products such as Spend bridge the gap between TradFi, Web2 and Web3. Mercuryo is the proud partner of leading pillars in the digital token economy such as Ledger, MetaMask, Trust Wallet and Revolut. Driven by an evolving product suite, Mercuryo is expanding further and continuing to innovate with a diversified stack of payment services.

This partnership underscores Bybit’s ongoing commitment to lowering barriers to entry in the digital asset space. Through customer-centric initiatives, Bybit strives to make crypto more accessible to users everywhere, particularly in growing markets where digital asset adoption is accelerating.

Bybit Partners with Mercuryo to Offer Zero Transaction Fee for Crypto Purchases in Selected Markets
Bybit Partners with Mercuryo to Offer Zero Transaction Fee for Crypto Purchases in Selected Markets

Terms and conditions apply. To find out more about eligibility requirements and restrictions, including supported fiat currencies, users may visit: [Bybit Fiat x Mercuryo exclusive] Enjoy 0% fees on One-Click Buy crypto purchases

#Bybit / #CryptoArk / #IMakeIt 

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

About Mercuryo

Mercuryo is a leading payment infrastructure platform in the digital token space. Standing out in the decentralized ecosystem by enhancing payment use case growth and on-chain integration, Mercuryo’s intuitive and robust solutions are powering the next generation of Web3 payment services. Mercuryo’s innovative payment products such as Spend bridge the gap between TradFi, Web2 and Web3. Mercuryo is the proud partner of leading pillars in the digital token economy such as Ledger, MetaMask, Trust Wallet and Revolut. Driven by an evolving product suite, Mercuryo is expanding further and continuing to innovate with a diversified stack of payment services.

Learn more at: https://mercuryo.io/

Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia

SHANGHAI, Feb. 6, 2026 /PRNewswire/ — Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration (NMPA). This follows the successful completion of Clinical Trial Notification (CTN) procedures and ethics committee approval in Australia in January 2026. Delonix plans to initiate Phase I clinical trials in the near term to evaluate the safety and immunogenicity of DX-104 in human subjects.

Invasive meningococcal disease (IMD) is a life-threatening bacterial infection that disproportionately impacts infants, adolescents, and young adults. Serogroup B has emerged as a predominant cause of IMD globally, accounting for approximately 50% of cases with a rising prevalence trend. While vaccines like GSK’s Bexsero® and Pfizer’s Trumenba® have established the commercial and clinical value of MenB prevention—with Bexsero recording approximately $1.58 billion in sales in 2025—significant global gaps in access and strain coverage remain.

DX-104 is an engineered MenB vaccine candidate developed using Delonix’s proprietary OMV Plus® platform. The platform leverages precisely engineered outer membrane vesicles (OMVs) with intrinsic adjuvant properties to optimize immunogenicity. In preclinical studies, DX-104 induced robust serum bactericidal antibody (SBA) responses without the need for external adjuvants. Furthermore, DX-104 has achieved commercial-scale production with high batch-to-batch consistency, ensuring a reliable global supply chain as the candidate advances toward potential commercialization.

“The dual regulatory clearances in China and Australia mark a transformative milestone for Delonix Bioworks as we transition into a clinical-stage company,” said Qiubin Lin, CEO and Founder of Delonix Bioworks. “This is a crucial step in our global strategy to deploy engineered bacterial vaccines that are designed to be highly immunogenic, well-tolerated, and scalable. We are committed to addressing the urgent unmet medical needs of patients worldwide.”

About Delonix Bioworks
Delonix Bioworks is a clinical-stage biotechnology company at the forefront of developing next-generation genetically engineered bacterial vaccines. Leveraging its proprietary OMV Plus® platform, the company produces high-yield, cost-effective, and precisely engineered outer membrane vesicles (OMVs) designed for superior antigen presentation and immunogenicity. Delonix is dedicated to advancing a robust pipeline of first-in-class and best-in-class programs addressing critical unmet needs, including vaccines for Meningococcal B, pertussis, gonorrhoeae, and K. pneumoniae.

For more information, please visit https://delonixbio.com/ or contact BD@delonixbio.com

LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders

BEIJING, Feb. 6, 2026 /PRNewswire/ — LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a notice, dated February 4, 2026, from legal counsel to a group (the “Buyer Group”) consisting of Oceanpine Skyline Inc. (“Parent”), Oceanpine Merger Sub Inc. (“Merger Sub”), Oceanpine Capital Inc., Oceanpine Investment Fund II LP, Crystal Peak Investment Inc., Adjuvant Global Health Technology Fund, L.P., Adjuvant Global Health Technology Fund DE, L.P., Superstring Capital Master Fund LP, MSA GROWTH FUND II, L.P., and Epiphron Capital (Hong Kong) Limited, relating to the previously announced going-private transaction of the Company whereby the Buyer Group agreed to take the Company private at a price of $0.90 per share pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated November 4, 2025, by and among the Company, Parent and Merger Sub.

According to the notice, the Buyer Group asserted that the arbitral awards received by the Company from the Kaifeng Arbitration Commission on January 21 and January 22, 2026—previously disclosed in the Company’s current report on Form 6-K furnished with the Securities and Exchange Commission (the “SEC”) on January 29, 2026—and the resulting financial liability of approximately RMB576,500,000 constitute a “Company Material Adverse Effect” under the Merger Agreement.

The Buyer Group asserted that a condition precedent to Parent’s obligation to close the Merger (as defined in the Merger Agreement) is that no Company Material Adverse Effect (as defined in the Merger Agreement) shall have occurred, and the Buyer Group has determined that a Company Material Adverse Effect has occurred and that the Buyer Group has the right not to consummate the Merger. The Buyer Group indicated that it would not attend or cast votes at the upcoming extraordinary general meeting (the “EGM”), scheduled for February 12, 2026, to consider and vote on, among other matters, the proposal to authorize and approve the Merger Agreement, the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, and the transactions contemplated thereby, including the Merger.

The Buyer Group expressed its willingness to engage in good faith discussions with the Company to explore amendments to the transaction terms to facilitate a mutually acceptable resolution and the successful completion of the transaction.

In light of this development, the Company has decided to postpone the previously announced EGM. Any proxy cards that have been submitted to the Company in respect of the EGM will be disregarded. Shareholders of record as of 5 p.m. Cayman Islands time on January 16, 2026 will each receive a copy of the notice regarding the postponement of the EGM. The notice will also be available on the Company’s website at https://investors.lakeshorebio.com/index.html and on the SEC’s website at http://www.sec.gov.

The Company will carefully review and evaluate the Buyer Group’s claims and the Company’s options, and will provide further updates as required under applicable law.

About LakeShore Biopharma Co., Ltd

LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry.

For more information, please visit https://investors.lakeshorebio.com/.

Forward-Looking Statements

This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements include, without limitation, the Company’s business plans and development, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “future,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. LakeShore Biopharma may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about LakeShore Biopharma’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the possibility that events may arise that result in the termination or amendment of the Merger Agreement; the possibility that competing offers will be made; the possibility that financing may not be available; the possibility that various closing conditions for the transaction may not be satisfied or waived; and other risks and uncertainties discussed in documents filed with the SEC by the Company, as well as the Schedule 13E-3 and the proxy statement filed by the Company; the Company’s goals and strategies; the Company’s future business development, financial condition and results of operations; its ability to provide efficient services and compete effectively; its ability to maintain and enhance the recognition and reputation of its brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

For investor inquiries, please contact:

IR Team
Tel: +86 (10) 8920-2086
Email: ir@lakeshorebio.com

CQG Enters into Agreement for Acquisition by Broadridge

Combination to Create End-to-End Trading Suite for Global Futures and Options Markets

DENVER, Feb. 6, 2026 /PRNewswire/ — CQG, a leading provider of futures and options trading, execution management and market connectivity, today announced it has entered into an agreement with global Fintech leader Broadridge Financial Solutions, Inc. (NYSE:BR) for Broadridge to acquire CQG. CQG will add complementary execution management, algorithmic trading and analytics capabilities to Broadridge’s order management and client connectivity solutions, creating an end-to-end trading suite for global futures and options markets.

“Our combined capabilities will provide a global multi-asset class trading experience defined by speed, scale and intelligence,” said Ryan Moroney, CEO of CQG. “Broadridge’s deep global reach and front-to-back capabilities and our expertise in front-office execution management and connectivity will enable clients to trade smarter, access new markets and adapt faster in an increasingly connected futures and options marketplace. The CQG team is truly excited to join a company with the history and successful track record of Broadridge.”

“The acquisition of CQG will accelerate Broadridge’s mission to deliver advanced, highly connected trading solutions on a global scale,” said Frank Troise, President of Broadridge’s Trading and Connectivity Solutions business. “Integrating CQG’s advanced execution management, analytics and connectivity technologies with Broadridge’s leading order management and connectivity solutions will create a unified platform in futures and options that simplifies trading complexity, improves transparency and workflow efficiency, and enhances Broadridge’s digital asset trading capabilities.”

Moroney added: “Broadridge has been a terrific partner since we decided to integrate some of our technologies a few years ago, and the team has made it clear they value our talented employees, culture, loyal client base, rapid delivery of new functionality and innovation. In this fast-moving environment, we believe the shared values between our firms, along with our combined global reach, significant resources and complementary technology make this transaction so compelling for CQG and exactly the right step for our employees and customers.”

Terms of the transaction, which are not expected to have a material impact on Broadridge’s financial results, were not disclosed. The transaction is expected to close early in Broadridge’s fiscal fourth quarter that ends June 30, subject to customary closing conditions, including regulatory approvals.

The expanded offering is designed to better support the evolving end-to-end needs of clients across a broad spectrum of segments, including futures commission merchants (FCMs), institutional investors, retail brokers, proprietary trading firms, commodity trading advisors (CTAs) and hedge funds. Clients will benefit from flexible, scalable solutions designed to support their growth objectives, accelerate speed to market, and deliver a powerful, fully integrated trading experience for institutional and professional retail market participants alike.

About CQG

CQG provides the industry’s highest performing solutions for traders, brokers, commercial hedgers and exchanges for their market-related activities globally, including trading, market data, advanced technical analysis, risk management, and account administration. The firm partners with the vast majority of futures brokerage and clearing firms and provides Direct Market Access (DMA) to more than 45 exchanges through its global network of co-located Hosted Exchange Gateways. CQG technology serves as the front end for a variety of exchanges and is increasingly employed as the over-the-counter matching engine for important new markets. CQG’s server-side order management tools for spreading, market aggregation, and smart orders are unsurpassed for speed and ease of use. Its market data feed consolidates 85 sources, including exchanges worldwide for futures, options, fixed income, foreign exchange, and equities, as well as data on debt securities, industry reports, and financial indices. One of the longest-serving technology solutions providers in the industry, CQG has won numerous awards for its trading software, technical analysis and multi-asset trading platform. CQG is headquartered in Denver, with sales and support offices and data centers in key markets globally, providing services in more than 60 countries. For more information, visit www.cqg.com.  

About Broadridge

Broadridge Financial Solutions (NYSE: BR) is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate and grow. The firm powers investing, governance and communications for its clients – driving operational resiliency, elevating business performance and transforming investor experiences.

Broadridge’s technology and operations platforms process and generate over 7 billion communications annually and underpin the daily average trading of over $15 trillion in equities, fixed income and other securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing over 15,000 associates in 21 countries.

For more information, visit www.broadridge.com.